FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282938211> ?p ?o ?g. }

• W4282938211 endingPage "4266" @default.
• W4282938211 startingPage "4258" @default.
• W4282938211 abstract "Abstract Purpose: We evaluated outcomes of unrelated transplantation for primary refractory/relapsed (ref/rel) acute myeloid leukemia (AML), comparing two cohorts according to the year of transplant, 2000–2009 and 2010–2019. Patients and Methods: Multivariable analyses were performed using the Cox proportional-hazards regression model. Results: 3,430 patients were included; 876 underwent a transplant between 2000–2009 and 2554 in 2010–2019. Median follow-up was 8.7 (95% CI, 7.8–9.4) and 3.4 (95% CI, 3.1–3.6) years (P &lt; 0.001). Median age was 52 (18–77) and 56 (18–79) years (P &gt; 0.0001); 45.5% and 55.5% had refractory AML while 54.5% and 44.5% had relapsed AML. Conditioning was myeloablative in 60% and 52%, respectively. Neutrophil recovery and day 100 incidence of acute and 2-year incidence of chronic graft-versus-host disease (GvHD) were similar between the two periods. Two-year relapse incidence was higher for patients undergoing transplant in the 2000–2009 period versus those undergoing transplant in 2010–2019: 50.2% versus 45.1% (HR, 0.85; 95% CI, 0.74–0.97; P = 0. 002). Leukemia-free survival; overall survival; and GvHD-free, relapse-free survival were lower for the 2000–2009 period: 26% versus 32.1% (HR, 0.87; 95% CI, 0.78–0.97; P = 0.01), 32.1% versus 38.1% (HR, 0.86; 95% CI, 0.77–0.96; P = 0.01), and 21.5% versus 25.3% (HR, 0.89; 95% CI, 0.81–0.99; P = 0.03), respectively. Two-year nonrelapse mortality was not significantly different (23.8% vs. 23.7%; HR, 0.91; 95% CI, 0.76–1.11; P = 0.34). Conclusions: Outcome of unrelated transplantation for patients with ref/rel AML has improved in the last two decades, rescuing about one third of the patients. See related commentary by Adrianzen-Herrera and Shastri, p. 4167" @default.
• W4282938211 created "2022-06-16" @default.
• W4282938211 creator A5001646221 @default.
• W4282938211 creator A5002578778 @default.
• W4282938211 creator A5006288618 @default.
• W4282938211 creator A5013231760 @default.
• W4282938211 creator A5018033667 @default.
• W4282938211 creator A5020996390 @default.
• W4282938211 creator A5023183268 @default.
• W4282938211 creator A5027516224 @default.
• W4282938211 creator A5035666187 @default.
• W4282938211 creator A5039007673 @default.
• W4282938211 creator A5040417184 @default.
• W4282938211 creator A5040563532 @default.
• W4282938211 creator A5042552205 @default.
• W4282938211 creator A5042951988 @default.
• W4282938211 creator A5051728974 @default.
• W4282938211 creator A5053860790 @default.
• W4282938211 creator A5058925624 @default.
• W4282938211 creator A5059188766 @default.
• W4282938211 creator A5059223544 @default.
• W4282938211 creator A5060295441 @default.
• W4282938211 creator A5068674008 @default.
• W4282938211 creator A5068727758 @default.
• W4282938211 creator A5070706427 @default.
• W4282938211 creator A5072437531 @default.
• W4282938211 creator A5079124367 @default.
• W4282938211 creator A5081701091 @default.
• W4282938211 creator A5088962035 @default.
• W4282938211 date "2022-06-07" @default.
• W4282938211 modified "2023-10-03" @default.
• W4282938211 title "Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis" @default.
• W4282938211 cites W1861829463 @default.
• W4282938211 cites W1978164777 @default.
• W4282938211 cites W1993355390 @default.
• W4282938211 cites W2005256320 @default.
• W4282938211 cites W2044088883 @default.
• W4282938211 cites W2074326274 @default.
• W4282938211 cites W2077173355 @default.
• W4282938211 cites W2090352304 @default.
• W4282938211 cites W2143034151 @default.
• W4282938211 cites W2150506134 @default.
• W4282938211 cites W2284574660 @default.
• W4282938211 cites W2340869536 @default.
• W4282938211 cites W2424060136 @default.
• W4282938211 cites W2559537906 @default.
• W4282938211 cites W2604688936 @default.
• W4282938211 cites W2769990542 @default.
• W4282938211 cites W2898523261 @default.
• W4282938211 cites W2898996397 @default.
• W4282938211 cites W2916023265 @default.
• W4282938211 cites W3001829780 @default.
• W4282938211 cites W3083549720 @default.
• W4282938211 cites W3087258385 @default.
• W4282938211 cites W3087499074 @default.
• W4282938211 cites W3090298178 @default.
• W4282938211 cites W3111076304 @default.
• W4282938211 cites W3130903278 @default.
• W4282938211 cites W3131348164 @default.
• W4282938211 cites W3158896377 @default.
• W4282938211 cites W3178721713 @default.
• W4282938211 cites W4231346141 @default.
• W4282938211 cites W4247507468 @default.
• W4282938211 doi "https://doi.org/10.1158/1078-0432.ccr-22-0809" @default.
• W4282938211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35670780" @default.
• W4282938211 hasPublicationYear "2022" @default.
• W4282938211 type Work @default.
• W4282938211 citedByCount "8" @default.
• W4282938211 countsByYear W42829382112022 @default.
• W4282938211 countsByYear W42829382112023 @default.
• W4282938211 crossrefType "journal-article" @default.
• W4282938211 hasAuthorship W4282938211A5001646221 @default.
• W4282938211 hasAuthorship W4282938211A5002578778 @default.
• W4282938211 hasAuthorship W4282938211A5006288618 @default.
• W4282938211 hasAuthorship W4282938211A5013231760 @default.
• W4282938211 hasAuthorship W4282938211A5018033667 @default.
• W4282938211 hasAuthorship W4282938211A5020996390 @default.
• W4282938211 hasAuthorship W4282938211A5023183268 @default.
• W4282938211 hasAuthorship W4282938211A5027516224 @default.
• W4282938211 hasAuthorship W4282938211A5035666187 @default.
• W4282938211 hasAuthorship W4282938211A5039007673 @default.
• W4282938211 hasAuthorship W4282938211A5040417184 @default.
• W4282938211 hasAuthorship W4282938211A5040563532 @default.
• W4282938211 hasAuthorship W4282938211A5042552205 @default.
• W4282938211 hasAuthorship W4282938211A5042951988 @default.
• W4282938211 hasAuthorship W4282938211A5051728974 @default.
• W4282938211 hasAuthorship W4282938211A5053860790 @default.
• W4282938211 hasAuthorship W4282938211A5058925624 @default.
• W4282938211 hasAuthorship W4282938211A5059188766 @default.
• W4282938211 hasAuthorship W4282938211A5059223544 @default.
• W4282938211 hasAuthorship W4282938211A5060295441 @default.
• W4282938211 hasAuthorship W4282938211A5068674008 @default.
• W4282938211 hasAuthorship W4282938211A5068727758 @default.
• W4282938211 hasAuthorship W4282938211A5070706427 @default.
• W4282938211 hasAuthorship W4282938211A5072437531 @default.
• W4282938211 hasAuthorship W4282938211A5079124367 @default.
• W4282938211 hasAuthorship W4282938211A5081701091 @default.
• W4282938211 hasAuthorship W4282938211A5088962035 @default.

• next